Search - tctmd.com

Displaying 281 - 300 of 501

Sort: Relevancy | Date

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

News Daily News

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Alison Palkhivala

May 23, 2017

Intracoronary Shot of Morphine Fails to Limit Myocardial Infarct Size

News Daily News

Intracoronary Shot of Morphine Fails to Limit Myocardial Infarct Size

Michael O'Riordan

April 07, 2017

Prioritizing Impella Support May Boost Cardiogenic Shock Survival, Pilot Study Suggests

News Conference News ACC 2017

Prioritizing Impella Support May Boost Cardiogenic Shock Survival, Pilot Study Suggests

March 22, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

News Daily News

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

January 19, 2017

News Daily News

Conflict Persists Between Guidelines and Practice When It Comes to Treating CAD in TAVR Candidates

December 08, 2016

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

November 17, 2016

News Conference News TCT 2016

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Yael L. Maxwell

November 01, 2016

Coronary Venous Angioplasty for CRT-D LV Lead Placement

Presentation TCT 2016

Coronary Venous Angioplasty for CRT-D LV Lead Placement

Presenter: George D. Dangas, Arindam Pande

October 31, 2016

When Mechanical Support During Primary PCI for LV Dysfunction Is Needed: When to Use IABP, Impella, TandemHeart, and/or ECMO

Presentation TCT 2016

When Mechanical Support During Primary PCI for LV Dysfunction Is Needed: When to Use IABP, Impella, TandemHeart, and/or ECMO

Presenter: Cindy L. Grines, Holger Thiele

October 31, 2016

From Severe LV Dysfunction Without Heart Failure to Killip Class III and IV: Who Needs Mechanical Hemodynamic Support During Primary PCI?

Presentation TCT 2016

From Severe LV Dysfunction Without Heart Failure to Killip Class III and IV: Who Needs Mechanical Hemodynamic Support During Primary PCI?

Presenter: Cindy L. Grines, Holger Thiele, Vladimir Dzavik

October 31, 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

October 29, 2016

News Daily News

研究称缺血性心肌病的患者可以受益于心肌卸负荷

Michael O'Riordan

October 17, 2016

News Daily News

Según un Estudio Los Pacientes con Cardiomiopatía Isquémica se Benefician de Descargas Miocárdicas

Michael O'Riordan

October 17, 2016

News Daily News

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Michael O'Riordan

October 17, 2016

News Daily News

STEMI 患者 CTO PCI 前沿：EXPLORE 带来更多问题

Yael L. Maxwell

October 05, 2016

News Daily News

On the Frontier of CTO PCI for STEMI Patients: Answers Lead to More Questions in EXPLORE

Yael L. Maxwell

October 05, 2016

News Daily News

En la Frontera de las PCI para el Manejo de OTC para Pacientes STEMI: Las Respuestas Llevan a Más Preguntas en el EXPLORE

Yael L. Maxwell

October 05, 2016

News Industry News

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016

News Daily News

Targeting PCI Readmissions at the Facility Level May Not Lessen Mortality: VA Study

September 21, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.